FR2074627A1 - Ppsoriasis treatment compsn - Google Patents

Ppsoriasis treatment compsn

Info

Publication number: FR2074627A1
Authority: FR; France
Prior art keywords: pref; treatment; composn; effects; ppsoriasis
Prior art date: 1970-01-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

FR7000991A

Other languages

English (en)

Other versions

FR2074627B1 (fr

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SOCRES

Original Assignee

SOCRES

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1970-01-13

Filing date

1970-01-13

Publication date

1971-10-08

1970-01-13 Application filed by SOCRES filed Critical SOCRES

1970-01-13 Priority to FR7000991A priority Critical patent/FR2074627A1/fr

1971-01-13 Priority to DE19712101393 priority patent/DE2101393A1/de

1971-10-08 Publication of FR2074627A1 publication Critical patent/FR2074627A1/fr

1973-01-12 Application granted granted Critical

1973-01-12 Publication of FR2074627B1 publication Critical patent/FR2074627B1/fr

Status Granted legal-status Critical Current

Links

201000004681 Psoriasis Diseases 0.000 abstract 2
DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 abstract 2
102000004190 Enzymes Human genes 0.000 abstract 1
108090000790 Enzymes Proteins 0.000 abstract 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
108010003272 Hyaluronate lyase Proteins 0.000 abstract 1
102000001974 Hyaluronidases Human genes 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
206010046996 Varicose vein Diseases 0.000 abstract 1
DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 abstract 1
229960004266 acetylcholine chloride Drugs 0.000 abstract 1
239000000443 aerosol Substances 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
239000006071 cream Substances 0.000 abstract 1
229960001912 dicoumarol Drugs 0.000 abstract 1
230000000916 dilatatory effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229940088598 enzyme Drugs 0.000 abstract 1
239000006260 foam Substances 0.000 abstract 1
208000014617 hemorrhoid Diseases 0.000 abstract 1
229920000669 heparin Polymers 0.000 abstract 1
229960002773 hyaluronidase Drugs 0.000 abstract 1
235000015110 jellies Nutrition 0.000 abstract 1
239000008274 jelly Substances 0.000 abstract 1
231100000957 no side effect Toxicity 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
210000005259 peripheral blood Anatomy 0.000 abstract 1
239000011886 peripheral blood Substances 0.000 abstract 1
208000001297 phlebitis Diseases 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
208000027185 varicose disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR7000991A 1970-01-13 1970-01-13 Ppsoriasis treatment compsn Granted FR2074627A1 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
FR7000991A FR2074627A1 (en)	1970-01-13	1970-01-13	Ppsoriasis treatment compsn
DE19712101393 DE2101393A1 (de)	1970-01-13	1971-01-13	Medikament zur Behandlung von Psoriasis

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR7000991A FR2074627A1 (en)	1970-01-13	1970-01-13	Ppsoriasis treatment compsn

Publications (2)

Publication Number	Publication Date
FR2074627A1 true FR2074627A1 (en)	1971-10-08
FR2074627B1 FR2074627B1 (fr)	1973-01-12

Family

ID=9048920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7000991A Granted FR2074627A1 (en)	1970-01-13	1970-01-13	Ppsoriasis treatment compsn

Country Status (2)

Country	Link
DE (1)	DE2101393A1 (fr)
FR (1)	FR2074627A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998036733A3 (fr) *	1997-02-24	1998-11-26	Michael Albert Kamm	Composition pharmaceutique a usage local contenant un agent cholinergique ou un inhibiteur calcique
EP1085859A4 (fr) *	1998-06-11	2003-02-26	Univ New Jersey Med	Traitement des blessures par inhibition d'adenosine diphosphate-ribosyl transferase
US8048875B1 (en)	1997-02-24	2011-11-01	S.L.A. Pharma Ag	Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5037810A (en) *	1987-03-17	1991-08-06	Saliba Jr Michael J	Medical application for heparin and related molecules

1970
- 1970-01-13 FR FR7000991A patent/FR2074627A1/fr active Granted
1971
- 1971-01-13 DE DE19712101393 patent/DE2101393A1/de active Pending

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998036733A3 (fr) *	1997-02-24	1998-11-26	Michael Albert Kamm	Composition pharmaceutique a usage local contenant un agent cholinergique ou un inhibiteur calcique
US8048875B1 (en)	1997-02-24	2011-11-01	S.L.A. Pharma Ag	Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US8318721B2 (en)	1997-02-24	2012-11-27	S.L.A. Pharma Ag	Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US8906903B2 (en)	1997-02-24	2014-12-09	S.L.A. Pharma Ag	Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
EP1085859A4 (fr) *	1998-06-11	2003-02-26	Univ New Jersey Med	Traitement des blessures par inhibition d'adenosine diphosphate-ribosyl transferase

Also Published As

Publication number	Publication date
FR2074627B1 (fr)	1973-01-12
DE2101393A1 (de)	1971-09-02

Publication	Publication Date	Title
CA977705A (en)	1975-11-11	Simultaneous production of aromatic hydrocarbons and isobutane
AU465217B2 (en)	1975-09-18	Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol
AU459618B2 (en)	1975-04-10	Treatment of timber
FR2074627A1 (en)	1971-10-08	Ppsoriasis treatment compsn
CA976365A (en)	1975-10-21	Methods of producing superconductors
CA1010881A (fr)	1977-05-24	Procede de preparation de nouveaux derives de l'acide butyrique
CA969885A (en)	1975-06-24	Simultaneous production of aromatic hydrocarbons and isobutane
CA989873A (en)	1976-05-25	Catalytic production of 1,1-difluoroethane
AU471853B2 (en)	1976-05-06	Enzyme treatment of legumes and derived products
CA936653A (en)	1973-11-13	Treatment of titanium dioxide
CA987314A (en)	1976-04-13	Derivatives of 9-oxo-13-trans-prostenoic acid esters
AU468132B2 (en)	1976-01-08	Process forthe preparation of chloroformic acid esters and cyclic carbonates
CA990670A (en)	1976-06-08	Enzymatic production of 6-aminopenicillanic acid
CA864531A (en)	1971-02-23	Enzymic treatment of natural products
CA978691A (en)	1975-11-25	Polyimides and methods of producing same
CA975371A (en)	1975-09-30	1-esters of 3-organosulfonyl-2-aza-succinic acid and base addition salts thereof
CA868943A (en)	1971-04-20	PRODUCTION OF .alpha.-CHLOROPROPIONIC ACID
CA866180A (en)	1971-03-16	Method of producing anti-adrenal activity and compositions therefor
CA880793A (en)	1971-09-14	Manufacture of titanium dioxide
AU443748B2 (en)	1972-09-28	Process forthe manufacture of optically active bicycloalkane derivatives
CA877981A (en)	1971-08-10	Production of o-benzoylbenzoic acid
CA605951A (en)	1960-09-27	Method of creping tissue and product thereof
AU241318B2 (en)	1960-08-11	Process forthe manufacture of titanium dioxide
AU423068B2 (en)	1972-04-27	Prophylaxis and treatment of cardiac disorders
CA860920A (en)	1971-01-12	Racemization of optically active transcyclopropanecarboxylic acids and their derivatives